Adam Lipman is a venture capital investor at Ecliptic Capital who spent over a decade at Genentech/Roche rising to Associate Director and later served as COO at software companies, giving him an unusually hands-on operational background spanning both large-scale biotech manufacturing and digital product development. He focuses on helping portfolio companies build the operational systems needed for growth and serves as Ecliptic's Chief Investment Officer, taking board observer roles where he applies his experience in scalable processes and resource management. Adam Lipman is a venture capital investor at Ecliptic Capital who spent over a decade at Genentech/Roche rising to Associate Director and later served as COO at software companies, giving him an unusually hands-on operational background spanning both large-scale biotech manufacturing and digital product development. He focuses on helping portfolio companies build the operational systems needed for growth and serves as Ecliptic's Chief Investment Officer, taking board observer roles where he applies his experience in scalable processes and resource management.